Cargando…

Intravitreal Daptomycin for Recalcitrant Postoperative Endophthalmitis

PURPOSE: To report the first case to our knowledge of intravitreal daptomycin used to successfully treat culture-negative vancomycin resistant to exogenous endophthalmitis. METHODS: Case report with preoperative, intraoperative, and postoperative findings. RESULTS: A 63-year-old Caucasian male under...

Descripción completa

Detalles Bibliográficos
Autores principales: Sim, Jennifer M., Kapoor, Kapil G., Wagner, Alan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899650/
https://www.ncbi.nlm.nih.gov/pubmed/27293409
http://dx.doi.org/10.1159/000444046
_version_ 1782436501785673728
author Sim, Jennifer M.
Kapoor, Kapil G.
Wagner, Alan L.
author_facet Sim, Jennifer M.
Kapoor, Kapil G.
Wagner, Alan L.
author_sort Sim, Jennifer M.
collection PubMed
description PURPOSE: To report the first case to our knowledge of intravitreal daptomycin used to successfully treat culture-negative vancomycin resistant to exogenous endophthalmitis. METHODS: Case report with preoperative, intraoperative, and postoperative findings. RESULTS: A 63-year-old Caucasian male underwent routine pars plana vitrectomy with epiretinal membrane peeling. He developed acute postoperative endophthalmitis, and underwent vitreous tap and injection of intravitreal vancomycin/ceftazidime/dexamethasone. Gram stain showed Gram-positive cocci, but cultures were negative. His infection subsequently proved very recalcitrant and his treatment course involved pars plana vitrectomy with anterior chamber washout and repeat injection of antibiotics, followed by repeat intravitreal vancomycin and ceftazidime. Ultimately, a second vitrectomy with intravitreal daptomycin controlled his intraocular infection. On each occasion, cultures were negative. CONCLUSION: This case suggests that vancomycin resistance should be considered in culture-negative postoperative endophthalmitis, and intravitreal daptomycin should be considered as an important treatment alternative. Although vancomycin resistance is fairly rare in endophthalmitis, acknowledgment of its increasing occurrence rate is critical for optimal management.
format Online
Article
Text
id pubmed-4899650
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-48996502016-06-10 Intravitreal Daptomycin for Recalcitrant Postoperative Endophthalmitis Sim, Jennifer M. Kapoor, Kapil G. Wagner, Alan L. Case Rep Ophthalmol Published online: February, 2016 PURPOSE: To report the first case to our knowledge of intravitreal daptomycin used to successfully treat culture-negative vancomycin resistant to exogenous endophthalmitis. METHODS: Case report with preoperative, intraoperative, and postoperative findings. RESULTS: A 63-year-old Caucasian male underwent routine pars plana vitrectomy with epiretinal membrane peeling. He developed acute postoperative endophthalmitis, and underwent vitreous tap and injection of intravitreal vancomycin/ceftazidime/dexamethasone. Gram stain showed Gram-positive cocci, but cultures were negative. His infection subsequently proved very recalcitrant and his treatment course involved pars plana vitrectomy with anterior chamber washout and repeat injection of antibiotics, followed by repeat intravitreal vancomycin and ceftazidime. Ultimately, a second vitrectomy with intravitreal daptomycin controlled his intraocular infection. On each occasion, cultures were negative. CONCLUSION: This case suggests that vancomycin resistance should be considered in culture-negative postoperative endophthalmitis, and intravitreal daptomycin should be considered as an important treatment alternative. Although vancomycin resistance is fairly rare in endophthalmitis, acknowledgment of its increasing occurrence rate is critical for optimal management. S. Karger AG 2016-02-20 /pmc/articles/PMC4899650/ /pubmed/27293409 http://dx.doi.org/10.1159/000444046 Text en Copyright © 2016 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Published online: February, 2016
Sim, Jennifer M.
Kapoor, Kapil G.
Wagner, Alan L.
Intravitreal Daptomycin for Recalcitrant Postoperative Endophthalmitis
title Intravitreal Daptomycin for Recalcitrant Postoperative Endophthalmitis
title_full Intravitreal Daptomycin for Recalcitrant Postoperative Endophthalmitis
title_fullStr Intravitreal Daptomycin for Recalcitrant Postoperative Endophthalmitis
title_full_unstemmed Intravitreal Daptomycin for Recalcitrant Postoperative Endophthalmitis
title_short Intravitreal Daptomycin for Recalcitrant Postoperative Endophthalmitis
title_sort intravitreal daptomycin for recalcitrant postoperative endophthalmitis
topic Published online: February, 2016
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899650/
https://www.ncbi.nlm.nih.gov/pubmed/27293409
http://dx.doi.org/10.1159/000444046
work_keys_str_mv AT simjenniferm intravitrealdaptomycinforrecalcitrantpostoperativeendophthalmitis
AT kapoorkapilg intravitrealdaptomycinforrecalcitrantpostoperativeendophthalmitis
AT wagneralanl intravitrealdaptomycinforrecalcitrantpostoperativeendophthalmitis